Disease – Modifying Agents Market By Drug Class (Interferon Beta-1α/β, Natalizumab, Mitoxantrone) an
250 Pages Disease – Modifying Agents Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderIn the struggle to slow the progression of disease in many inflammatory conditions such as rheumatoid arthritis, psoriasis, and psoriatic arthritis, the disease-modifying agent class, including trea...
Source: pharmiweb.com